Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2010
11/10/2010CN101880677A siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof
11/10/2010CN101880675A High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application
11/10/2010CN101880651A Preparation method of Muscovy duck parvo novel vaccines
11/10/2010CN101880647A Recombinant salmonella choleraesuis, bivalent genetic engineering vaccine and application
11/10/2010CN101880640A Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain
11/10/2010CN101880328A Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
11/10/2010CN101880324A Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
11/10/2010CN101880318A Virus protein granules of hepatitis E virus-4 ORF2 fragment and prepration method and application thereof
11/10/2010CN101879317A Preparation method and application of Vibro harveyi and Vibrio parahaemolyticus bigeminy DNA vaccine
11/10/2010CN101879316A Genetic engineering vaccine as well as preparation method and application thereof in pharmacy
11/10/2010CN101879315A Polymalic acid prodrug derivant and applications thereof
11/10/2010CN101879312A Broad spectrum type influenza vaccine and preparation method thereof
11/10/2010CN101879311A Method for preparing live vaccines of hog cholera and product thereof
11/10/2010CN101643750B Construction method and applications of targeting oncolytic-adenovirus carier Ad-TD-gene
11/10/2010CN101612404B Heat-resisting lyophilized protectant for chicken newcastle disease and chicken infectious bronchitis dual living vaccine
11/10/2010CN101319011B Multi-type HCV-E1 epitope complex immunogen, encoding gene and application thereof
11/10/2010CN101235364B Newcastle disease virus D90 strain and application thereof
11/10/2010CN101186902B Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof
11/10/2010CN101092456B Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu
11/10/2010CN101036784B Toxicity T cell position vaccine of the cell for treating Hepatitis B and the preparing method
11/10/2010CN101028513B Production for beach vibrio piscium efficient vaccine
11/10/2010CA2759233A1 Method for making heteromultimeric molecules
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829678 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829674 Compositions and methods for binding sphingosine-1-phosphate
11/09/2010US7829673 comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:7 or encoded by the nucleotide sequence set forth in SEQ ID NO:6; inhibiting growth and/or proliferation of a cell expressing CD38; kits
11/09/2010US7829669 Catalytically active recombinant memapsin and methods of use thereof
11/09/2010US7829668 Analyzing amino acid sequences of cytokines and immunotoxins, then deleting selected tripeptides, to form mutant toxins used as vaccines
11/09/2010US7829667 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
11/09/2010US7829663 F11 receptor (F11R) antagonists as therapeutic agents
11/09/2010US7829537 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers
11/09/2010US7829331 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
11/09/2010US7829321 Method for the production of bacterial toxins
11/09/2010US7829276 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
11/09/2010US7829104 Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829102 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s)
11/09/2010US7829101 PCV2 immunogenic compositions and methods of producing such compositions
11/09/2010US7829100 vehicle comprising; a modified unsaturated oil and, optionally, a non-oxidizable oil; immediately after manufacture, composition can be administered such that the bioactive agents are released to the host on a predictable sustained basis.
11/09/2010US7829096 CD40L-specific monovalent polypeptides
11/09/2010US7829095 Produced by hybridoma cell line DSM ACC 2533
11/09/2010US7829094 multiple myeloma, acute myelogenous leukemia or chromic myelogenous leukemia; time-release and sustained-release drugs
11/09/2010US7829093 autoimmune vasculitis, graft versus host disease, multiple sclerosis, myasthenia gravis, and diabetes mellitus type I; time-release and sustained-release drugs
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829091 Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010US7829089 Antibody to mammalian cytokine-like polypeptide-10
11/09/2010US7829088 Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof
11/09/2010US7829087 Methods of treating cognitive impairment
11/09/2010US7829086 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/09/2010US7829085 Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
11/09/2010US7829083 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
11/09/2010US7829082 Catheter composition and uses thereof
11/09/2010US7829077 kit comprising an IFN- alpha selected from IFN- alpha -2a, IFN- alpha -2b, IFN- alpha -5, consensus interferon, purified IFN- alpha , pegylated IFN- alpha and a pharmaceutically acceptable quantity of oncostatin M
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2507470C Combinations of growth regulating factors and hormones for the treatment of neoplasia
11/09/2010CA2438544C Aerosol compositions containing formoterol for delivery to the lungs via nebulization
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/09/2010CA2342305C Pestivirus mutants and vaccines containing the same
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/09/2010CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/07/2010CA2665956A1 Combination treatment for ocular diseases
11/04/2010WO2010127294A2 Dual variable domain immunoglobulins and uses thereof
11/04/2010WO2010127284A2 Dual variable domain immunoglobulins and uses thereof
11/04/2010WO2010127280A1 High throughput assays for determining contractile function and devices for use therein
11/04/2010WO2010127258A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
11/04/2010WO2010127180A2 Dc-stamp antibodies
11/04/2010WO2010127172A2 Chimeric factor h binding proteins (fhbp) and methods of use
11/04/2010WO2010127166A2 Combination anti-hiv vectors, targeting vectors, and methods of use
11/04/2010WO2010127029A1 Methods for treating or preventing ophthalmological diseases
11/04/2010WO2010126967A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
11/04/2010WO2010126898A1 Methods for reducing the level of alloantibodies in a subject
11/04/2010WO2010126552A1 Potent cell-binding agent drug conjugates
11/04/2010WO2010126452A1 Molecular signature of human lung cancer initiating cells and uses thereof
11/04/2010WO2010126319A2 Lipopeptide with specific affinity to the fc region of an antibody, and antigen-recognizing lipid nanoparticle comprising same
11/04/2010WO2010126279A2 Cytokeratin 17-specific human antibody
11/04/2010WO2010126194A1 Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126151A1 Novel malaria vaccine
11/04/2010WO2010126074A1 Pharmaceutical composition for maintenance therapy which contains antibody capable of recognizing hla class-i as active ingredient
11/04/2010WO2010126066A1 Anti-il-3rα antibody for use in treatment of blood tumor
11/04/2010WO2010125762A1 Antibody-type rejection-preventing agent
11/04/2010WO2010125565A2 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
11/04/2010WO2010125544A1 Immunogenic nanomedicine composition and preparation and uses thereof
11/04/2010WO2010125480A1 Pneumococcal vaccine and uses thereof
11/04/2010WO2010125461A1 Adjuvanted vaccines for protecting against influenza
11/04/2010WO2010125162A1 Anti cxcr4 antibodies for the treatment of hiv
11/04/2010WO2010125014A1 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
11/04/2010WO2010125003A1 Compositions and methods for increasing muscle growth
11/04/2010WO2010124498A1 A resistance-screened tumor stem cell, its antigen composition, an anti-tumor dendritic cell loading with said antigens, their preparation methods, uses and kits thereof as well as a dendritic cell vaccine
11/04/2010WO2010124428A1 A stabilizer for preparing freeze-dried vaccine without gelatin and the preparation method of freeze-dried vaccine
11/04/2010WO2010124377A1 Mutants of francisella tularensis and uses thereof
11/04/2010WO2010124373A1 Influenza vaccine
11/04/2010WO2010124361A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
11/04/2010WO2010105128A3 A pkn3/rhoc macromolecular complex and methods of use therefor
11/04/2010WO2010089402A9 Splitting gp41
11/04/2010WO2010081173A3 Modified antibody compositions, methods of making and using thereof
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1823